MSH|^~\&|SendAppName^2.16.840.1.114222.444^ISO|Sending-Facility^2.16.840.1.114222.444^ISO|PHINCDS^2.16.840.1.114222.4.3.2.10^ISO|PHIN^2.16.840.1.114222^ISO|20140630120030.1234-0500||ORU^R01^ORU_R01|MESSAGE CONTROL ID|D|2.5.1|||||||||NOTF_ORU_v3.0^PHINProfileID^2.16.840.1.114222.4.10.3^ISO~Generic_MMG_V2.0^PHINMsgMapID^2.16.840.1.114222.4.10.4^ISO~Lyme_TBRD_MMG_V1.0^PHINMsgMapID^2.16.840.1.114222.4.10.4^ISO
PID|1||RZB_LAB_01^^^SendAppName&2.16.840.1.114222.3333&ISO||~^^^^^^S||19630401|M||2054-5^Black or African American^CDCREC|^^^51^22030|||||||||||2186-5^Not Hispanic or Latino^CDCREC
OBR|1||RZB_LAB_01^SendAppName^2.16.840.1.114222.3333^ISO|68991-9^Epidemiologic Information^LN|||20180605150000|||||||||||||||20180605150000|||F||||||11088^Ehrlichia chaffeensis^NND
OBX|1|CWE|78746-5^Country of Birth^LN||USA^UNITED STATES OF AMERICA^ISO3166_1||||||F
OBX|2|CWE|77983-5^Country of Usual Residence^LN||USA^UNITED STATES OF AMERICA^ISO3166_1||||||F
OBX|3|TS|11368-8^Date of Illness Onset^LN||20190601||||||F
OBX|4|TS|77976-9^Illness End Date^LN||20190620||||||F
OBX|5|SN|77977-7^Illness Duration^LN||^21|d^day [time]^UCUM|||||F
OBX|6|TS|77975-1^Diagnosis Date^LN||20180605||||||F
OBX|7|CWE|77974-4^Hospitalized^LN||Y^Yes^HL70136||||||F
OBX|8|TS|8656-1^Admission Date^LN||20190620||||||F
OBX|9|TS|8649-6^Discharge Date^LN||20190620||||||F
OBX|10|SN|78033-8^Duration of Hospital Stay in Days^LN||^13||||||F
OBX|11|CWE|77978-5^Subject Died^LN||N^No^HL70136||||||F
OBX|12|ST|77993-4^State Case Identifier^LN||340227||||||F
OBX|13|ST|77997-5^Legacy Case Identifier^LN||34022713S012018||||||F
OBX|14|SN|77998-3^Age at Case Investigation^LN||^55|a^year [time]^UCUM|||||F
OBX|15|CWE|77984-3^Country of Exposure^LN|1|USA^UNITED STATES OF AMERICA^ISO3166_1||||||F
OBX|16|CWE|77985-0^State or Province of Exposure^LN|1|51^Virginia^FIPS5_2||||||F
OBX|17|ST|77986-8^City of Exposure^LN|1|Oakton||||||F
OBX|18|ST|77987-6^County of Exposure^LN|1|Fairfax County||||||F
OBX|19|CWE|77989-2^Transmission Mode^LN||418427004^Vector-borne transmission^SCT||||||F
OBX|20|CWE|77990-0^Case Class Status Code^LN||2931005^Probable diagnosis^SCT||||||F
OBX|21|CWE|77965-2^Immediate National Notifiable Condition^LN||N^No^HL70136||||||F
OBX|22|CWE|77980-1^Case Outbreak Indicator^LN||N^No^HL70136||||||F
OBX|23|ST|77969-4^Jurisdiction Code^LN||S01||||||F
OBX|24|CWE|48766-0^Reporting Source Type Code^LN||PHC252^Other State and Local Agencies^CDCPHINVS||||||F
OBX|25|ST|52831-5^Reporting Source ZIP Code^LN||22030||||||F
OBX|26|ST|74549-7^Person Reporting to CDC - Name^LN||Mick Chopra||||||F
OBX|27|ST|74548-9^Person Reporting to CDC - Phone Number^LN||858-888-9999||||||F
OBX|28|ST|74547-1^Person Reporting to CDC - Email^LN||Chopra@email.com||||||F
OBX|29|DT|77979-3^Case Investigation Start Date^LN||20180605||||||F
OBX|30|DT|77995-9^Date Reported^LN||20180605||||||F
OBX|31|TS|77972-8^Earliest Date Reported to County^LN||20180605||||||F
OBX|32|TS|77973-6^Earliest Date Reported to State^LN||20180605||||||F
OBX|33|SN|77991-8^MMWR Week^LN||^23||||||F
OBX|34|DT|77992-6^MMWR Year^LN||2018||||||F
OBX|35|DT|77970-2^Date First Reported to PHD^LN||20180605||||||F
OBX|36|CWE|77966-0^Reporting State^LN||51^Virginia^FIPS5_2||||||F
OBX|37|CWE|77968-6^National Reporting Jurisdiction^LN||51^VA^FIPS5_2||||||F
OBX|38|CWE|INV929^Clinical Manifestation^PHINQUESTION|1|386661006^Fever^SCT||||||F
OBX|39|CWE|INV930^Clinical Manifestation Indicator^PHINQUESTION|1|N^No^HL70136||||||F
OBX|40|CWE|INV929^Clinical Manifestation^PHINQUESTION|2|271807003^Rash^SCT||||||F
OBX|41|CWE|INV930^Clinical Manifestation Indicator^PHINQUESTION|2|Y^Yes^HL70136||||||F
OBX|42|CWE|INV929^Clinical Manifestation^PHINQUESTION|3|87319000^Eschar^SCT||||||F
OBX|43|CWE|INV930^Clinical Manifestation Indicator^PHINQUESTION|3|N^No^HL70136||||||F
OBX|44|CWE|INV929^Clinical Manifestation^PHINQUESTION|4|25064002^Headache^SCT||||||F
OBX|45|CWE|INV930^Clinical Manifestation Indicator^PHINQUESTION|4|Y^Yes^HL70136||||||F
OBX|46|CWE|INV929^Clinical Manifestation^PHINQUESTION|5|68962001^Myalgia^SCT||||||F
OBX|47|CWE|INV930^Clinical Manifestation Indicator^PHINQUESTION|5|Y^Yes^HL70136||||||F
OBX|48|CWE|INV929^Clinical Manifestation^PHINQUESTION|6|271737000^Anemia^SCT||||||F
OBX|49|CWE|INV930^Clinical Manifestation Indicator^PHINQUESTION|6|N^No^HL70136||||||F
OBX|50|CWE|INV929^Clinical Manifestation^PHINQUESTION|7|419188005^Leukopenia^SCT||||||F
OBX|51|CWE|INV930^Clinical Manifestation Indicator^PHINQUESTION|7|N^No^HL70136||||||F
OBX|52|CWE|INV929^Clinical Manifestation^PHINQUESTION|8|302215000^Thrombocytopenia^SCT||||||F
OBX|53|CWE|INV930^Clinical Manifestation Indicator^PHINQUESTION|8|Y^Yes^HL70136||||||F
OBX|54|CWE|INV929^Clinical Manifestation^PHINQUESTION|9|PHC2108^Hepatic transaminase elevation^CDCPHINVS||||||F
OBX|55|CWE|INV930^Clinical Manifestation Indicator^PHINQUESTION|9|N^No^HL70136||||||F
OBX|56|CWE|INV1265^Experienced Complication^PHINQUESTION||Y^Yes^HL70136||||||F
OBX|57|CWE|67187-5^Type of Complication^LN||OTH^other^NULLFL||||||F
OBX|58|CWE|370388006^Patient Immunocompromised^SCT||Y^Yes^HL70136||||||F
OBX|59|ST|INV933^Immunocompromised Associated Condition or Treatment^PHINQUESTION||diabetes, renal disease||||||F
OBX|60|CWE|255633001^Treatment Drug Indicator^SCT||Y^Yes^HL70136||||||F
OBX|64|CWE|29303-5^Medication Administered^LN|1|723^Amoxicillin^RXNORM||||||F
OBX|65|DT|86948-7^Date Treatment or Therapy Started^LN|1|20180607||||||F
OBX|66|SN|67453-1^Treatment Duration^LN|1|^10|d^day^UCUM|||||F
OBX|67|CWE|INV1266^Occupation Related to Exposure^PHINQUESTION||N^No^HL70136||||||F
OBX|68|ST|85658-3^Current Occupation^LN|1|Data Analyst||||||F
OBX|69|CE|85659-1^Current Occupation Standardized^LN|1|0735^Market research analysts and marketing specialists [0735]^CDCOCCUPATION2010||||||F
OBX|70|ST|85078-4^Current Industry^LN|1|Banking||||||F
OBX|71|CE|85657-5^Current Industry Standardized^LN|1|6870^Banking and related activities [6870]^CDCINDUSTRY2010||||||F
OBX|72|CWE|420008001^Travel^SCT||Y^Yes^HL70136||||||F
OBX|73|CWE|82754-3^Travel State^LN|1|37^North Carolina^FIPS5_2||||||F
OBX|74|CWE|82753-5^Travel County^LN|1|37013^Beaufort, NC^FIPS6_4||||||F
OBX|75|DT|TRAVEL06^Date of Arrival to Travel Destination^PHINQUESTION|1|20180525||||||F
OBX|76|DT|TRAVEL07^Date of Departure from Travel Destination^PHINQUESTION|1|20180528||||||F
OBX|77|CWE|95898004^Tick Bite^SCT||N^No^HL70136||||||F
OBX|78|CWE|82312-0^Blood Transfusion^LN||N^No^HL70136||||||F
OBX|79|CWE|105470007^Blood Donor^SCT||N^No^HL70136||||||F
OBX|80|CWE|INV290^Test Type^PHINQUESTION|1|87559-1^PCR Ehrlichia chaffeensis^LN||||||F
OBX|81|CWE|INV291^Test Result^PHINQUESTION|1|10828004^Positive^SCT||||||F
OBX|82|CWE|LAB278^Organism Name^PHINQUESTION|1|59250001^Ehrlichia chaffeensis^SCT||||||F
OBX|83|ST|LAB628^Test Result Quantitative^PHINQUESTION|1|>1:64||||||F
OBX|84|TS|68963-8^Specimen Collection Date/Time^LN|1|20190613||||||F
OBX|85|CWE|66746-9^Specimen Type^LN|1|119364003^Serum^SCT||||||F
OBX|86|ST|68994-3^Performing Laboratory Name^LN|1|CDC RZB Reference Laboratory||||||F
OBX|87|CWE|INV1269^Laboratory State^PHINQUESTION|1|13^Georgia^FIPS5_2||||||F
OBX|88|ST|LAB202^Performing Laboratory Specimen ID^PHINQUESTION|1|99999||||||F